AIF Antibody

• Catalog Number: orb1239191
• Category: Antibodies
• Description: AIF Antibody
• Target: AIFM1
• Clonality: Polyclonal
• Isotype: IgG
• Conjugation: Unconjugated
• Reactivity: Human
• Predicted Reactivity: Mouse, Rat
• Form/Appearance: Liquid
• Concentration: 1 mg/ml
• Buffer/Preservatives: AIF Antibody is supplied in PBS containing 0.02% sodium azide.
• Purification: AIF Antibody is Ion exchange chromatography purified.
• Immunogen: Anti-AIF antibody (orb1239191) was raised against a peptide corresponding to 14 amino acids near the amino terminus of mature human AIF. The immunogen is located within amino acids 90-140 of AIF.
• UniProt ID: O95381
• MW: Predicted: 67 kDa Observed: 68 kDa
• Tested applications: ELISA, IF, WB
• Antibody Type: Primary Antibody
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Alternative names: AIF Antibody: Apoptosis-inducing factor 1, Program
• Note: For research use only
• NCBI: O95381

Western Blot Validation in Human Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: AIF orb1239191, (1 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Independent Antibody Validation (IAV) via Protein Expression Profile in Cell Lines. Loading: 15 µg of lysates per lane. Antibodies: AIF orb1239169, (1 µg/mL), AIF orb1239191, (1 µg/mL), AIF orb1239168, (2 µg/mL), and beta-actin (1 µg/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.

Immunofluorescence Validation of AIF in K562 Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed K562 Cells labeling AIF with orb1239191 at 20 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green).

KD and Induced Validation of AIF in H1299 Cells (Stambolsky et al., 2006). Western blot analysis of AIF knockdown with anti-AIF antibodies in H1299 cells. AIF expression was disrupted in AIF knockdown cells (siRNA1 and siRNA4). An increased expression of AIF was induced by ZnCl2 treatment, which was not observed in AIF knockdown cells.

KD Validation of AIF in AIF Silenced Stable Cells (Apostolova et al., 2006). AIF silencing is sustained in stable cell lines. Western blot analysis ofstable lines AIF-1-10, AIF-2-4 and pU6-2 using anti-AIF antibodies. AIF protein was disrupted after AIF silencing with AIF siRNA (AIF-1-10 and AIF-2-4) as compared to control (Hep3B and pU6-2).

Immunofluorescence Validation of AIF in Rat Hippocampal Neurons (Hofer et al., 2011). (G-L) After exposure to bacterial components, AIF colocalized in mature neurons (MAP2; I, L), immature neurons (DcX; H, K), and stem/progenitor cells (Nestin; G, J). AIF expression was detected by anti-AIF antibodies.

Subcellular Localization Validation of AIF in mononuclear cells (Gupta et al., 2003). A shows mononuclear cells (MNCs) alone, B shows MNCs transfected with control plasmid, C shows MNCs transfected with Bcl-2 expression plasmid. Overlay is of Mitotracker (red) and AIF (green). Hoechst 33258 dye is used to examine chromatin fragmentation. The release of AIF form mitochondria is detected by anti-AIF antibodies.

Induced Expression Validation of AIF in U937 Cells (Ikai et al., 2006). Release of AIF at 48 h after the treatment with 30 uM magnolol examined by Western blotAnalysis with anti-AIF antibodies. AIF release was markedly increased 48h after magnolol treatment.